EUVIMEDEUVIMED entdecken
Crossref

PHARMACODYNAMIC EFFECT OF SHIRISHADI TAILA: IN ADMINISTRATION OF NASYA FORM IN AUTISM

Deeplata Bunker, Neeraj Agrawal, Lowkesh Chandravanshi, Satyawati Rathiya, Manisha Sahu, Anamika Banjare, Dipesh Raj

International Journal of Drug Delivery Technology · 06.07.2026 · 16 (62s)

DOI: 10.25258/ijddt.16.62s.52 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 06.07.2026. Verfasst von Deeplata Bunker und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder characterized by difficulties in social interaction, communication, repetitive behaviours, and cognitive dysfunction. Current therapies mainly provide symptomatic improvement, while complete management remains challenging. Ayurveda correlates ASD manifestations with Kaphaja Unmada and emphasizes Medhya Rasayana, Nasya Karma, and Dosha-balancing therapies for cognitive and behavioural enhancement.

Objective

To review the pharmacodynamic and neuroprotective effects of selected Ayurvedic drugs used in the management of autism spectrum disorder and to explore their possible biochemical mechanisms.

Methods

A narrative review was conducted using classical Ayurvedic texts and published scientific literature related to ASD pathology and Ayurvedic medicinal plants. Various herbs, including Shirish (Albizia lebbeck), Lahsun (Allium sativum), Hingu (Ferula narthex), Nagar (Zingiber officinale), Yashtimadhu (Glycyrrhiza glabra), Vacha (Acorus calamus), Kustha (Saussurea costus), and Ajamutra, were reviewed for their pharmacological and biochemical activities relevant to ASD.

Results

The reviewed drugs demonstrated antioxidant, anti-inflammatory, neuroprotective, immunomodulatory, and gut– brain axis regulatory activities. Major mechanisms included suppression of oxidative stress and inhibition of inflammatory pathways such as NF-κB and TLR4, modulation of GABAergic and serotonergic neurotransmission, enhancement of synaptic plasticity, and improvement of cognitive function. Several herbs also exhibited bioavailability-enhancing and neuroprotective actions beneficial in behavioral and cognitive abnormalities associated with ASD.

Conclusion

Ayurvedic drugs have significant multi-target pharmacodynamic properties that may help manage core pathological mechanisms of ASD. Integrating Ayurvedic approaches with conventional therapies may offer supportive benefits in improving cognition, behavior, and quality of life in children with ASD.

Zitieren

APA

Bunker, D., Agrawal, N., Chandravanshi, L., Rathiya, S., Sahu, M., Banjare, A., & Raj, D. (2026). PHARMACODYNAMIC EFFECT OF SHIRISHADI TAILA: IN ADMINISTRATION OF NASYA FORM IN AUTISM. International Journal of Drug Delivery Technology, 16(62s). https://doi.org/10.25258/ijddt.16.62s.52

Vancouver

Bunker D, Agrawal N, Chandravanshi L, Rathiya S, Sahu M, Banjare A, et al. PHARMACODYNAMIC EFFECT OF SHIRISHADI TAILA: IN ADMINISTRATION OF NASYA FORM IN AUTISM. International Journal of Drug Delivery Technology. 2026;16(62s). doi:10.25258/ijddt.16.62s.52

BibTeX
@article{Bunker2026,
  author = {Bunker, Deeplata and Agrawal, Neeraj and Chandravanshi, Lowkesh and Rathiya, Satyawati and Sahu, Manisha and Banjare, Anamika and Raj, Dipesh},
  title = {PHARMACODYNAMIC EFFECT OF SHIRISHADI TAILA: IN ADMINISTRATION OF NASYA FORM IN AUTISM},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {62s},
  doi = {10.25258/ijddt.16.62s.52}
}
Kostenlos starten →